‘A bitter result’: Judge approves Purdue’s $4.5B opioid settlement that protects Sackler family from future lawsuitsnews2021-09-02T14:22:01+00:00September 2nd, 2021|Fierce Pharma|
Pfizer’s COVID-19 booster application set for high-stakes FDA advisory committee review in two weeksnews2021-09-02T13:27:57+00:00September 2nd, 2021|Fierce Pharma|
Pfizer’s COVID-19 booster application set for high-stakes FDA advisory committee review in 2 weeksnews2021-09-02T13:27:57+00:00September 2nd, 2021|Fierce Pharma|
Quotient Sciences casts $8.7M spell over its new Alnwick facility, adding drug substance capacity and 80 jobsnews2021-09-02T12:47:07+00:00September 2nd, 2021|Fierce Pharma|
FDA’s new JAK safety restrictions spell trouble for AbbVie’s Rinvoq, but to what extent?news2021-09-02T12:23:10+00:00September 2nd, 2021|Fierce Pharma|
JAK inhibitors from Pfizer, AbbVie and Lilly hit with dreaded FDA heart safety, cancer warningsnews2021-09-01T16:18:12+00:00September 1st, 2021|Fierce Pharma|
Biogen’s Aduhelm label far exceeds clinical trial population, study says. That could bring real-world surprisesnews2021-09-01T15:33:13+00:00September 1st, 2021|Fierce Pharma|
Sanofi pulls Epilim website after U.K. regulator points out consumer complaintnews2021-09-01T15:33:08+00:00September 1st, 2021|Fierce Pharma|
Merck’s Keytruda survives FDA scrutiny in bladder cancer, but ends up with a smaller labelnews2021-09-01T14:32:40+00:00September 1st, 2021|Fierce Pharma|
Moderna reveals source of COVID-19 vaccine contamination as Japan finds yet another suspect vialnews2021-09-01T13:30:19+00:00September 1st, 2021|Fierce Pharma|
